Virology Specimen Collection - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511242286

Publication Date:

November 6, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Virology Specimen Collection was estimated to be worth US$ 1836 million in 2023 and is forecast to a readjusted size of US$ 2425.8 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030
North American market for Virology Specimen Collection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Virology Specimen Collection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Virology Specimen Collection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Virology Specimen Collection include Becton,Dickinson and Company, Quidel Corporation, Trinity Biotech, Titan Biotech, Diasorin SA, Vircell S.L., Copan Italia S.P.A, Puritan Medical Products Co. and Hardy Diagnostics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Virology Specimen Collection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Virology Specimen Collection by region & country, by Type, and by Application.
The Virology Specimen Collection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Virology Specimen Collection.
麻豆原创 Segmentation
By Company
Becton,Dickinson and Company
Quidel Corporation
Trinity Biotech
Titan Biotech
Diasorin SA
Vircell S.L.
Copan Italia S.P.A
Puritan Medical Products Co.
Hardy Diagnostics
Cardinal Health
Sarstedt
FL Medical
Improve Medical
Segment by Type:
Blood Collection Kits
Specimen Collection Tubes
Viral Transport Media
Swabs
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Virology Specimen Collection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Virology Specimen Collection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Virology Specimen Collection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Virology Specimen Collection Product Introduction
1.2 Global Virology Specimen Collection 麻豆原创 Size Forecast
1.3 Virology Specimen Collection 麻豆原创 Trends & Drivers
1.3.1 Virology Specimen Collection Industry Trends
1.3.2 Virology Specimen Collection 麻豆原创 Drivers & Opportunity
1.3.3 Virology Specimen Collection 麻豆原创 Challenges
1.3.4 Virology Specimen Collection 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Virology Specimen Collection Players Revenue Ranking (2023)
2.2 Global Virology Specimen Collection Revenue by Company (2019-2024)
2.3 Key Companies Virology Specimen Collection Manufacturing Base Distribution and Headquarters
2.4 Key Companies Virology Specimen Collection Product Offered
2.5 Key Companies Time to Begin Mass Production of Virology Specimen Collection
2.6 Virology Specimen Collection 麻豆原创 Competitive Analysis
2.6.1 Virology Specimen Collection 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Virology Specimen Collection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virology Specimen Collection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Blood Collection Kits
3.1.2 Specimen Collection Tubes
3.1.3 Viral Transport Media
3.1.4 Swabs
3.2 Global Virology Specimen Collection Sales Value by Type
3.2.1 Global Virology Specimen Collection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Virology Specimen Collection Sales Value, by Type (2019-2030)
3.2.3 Global Virology Specimen Collection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceutical Companies
4.1.2 Academic and Research Institutes
4.2 Global Virology Specimen Collection Sales Value by Application
4.2.1 Global Virology Specimen Collection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Virology Specimen Collection Sales Value, by Application (2019-2030)
4.2.3 Global Virology Specimen Collection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Virology Specimen Collection Sales Value by Region
5.1.1 Global Virology Specimen Collection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Virology Specimen Collection Sales Value by Region (2019-2024)
5.1.3 Global Virology Specimen Collection Sales Value by Region (2025-2030)
5.1.4 Global Virology Specimen Collection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Virology Specimen Collection Sales Value, 2019-2030
5.2.2 North America Virology Specimen Collection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Virology Specimen Collection Sales Value, 2019-2030
5.3.2 Europe Virology Specimen Collection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Virology Specimen Collection Sales Value, 2019-2030
5.4.2 Asia Pacific Virology Specimen Collection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Virology Specimen Collection Sales Value, 2019-2030
5.5.2 South America Virology Specimen Collection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Virology Specimen Collection Sales Value, 2019-2030
5.6.2 Middle East & Africa Virology Specimen Collection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Virology Specimen Collection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Virology Specimen Collection Sales Value
6.3 United States
6.3.1 United States Virology Specimen Collection Sales Value, 2019-2030
6.3.2 United States Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Virology Specimen Collection Sales Value, 2019-2030
6.4.2 Europe Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Virology Specimen Collection Sales Value, 2019-2030
6.5.2 China Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.5.3 China Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Virology Specimen Collection Sales Value, 2019-2030
6.6.2 Japan Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Virology Specimen Collection Sales Value, 2019-2030
6.7.2 South Korea Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Virology Specimen Collection Sales Value, 2019-2030
6.8.2 Southeast Asia Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Virology Specimen Collection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Virology Specimen Collection Sales Value, 2019-2030
6.9.2 India Virology Specimen Collection Sales Value by Type (%), 2023 VS 2030
6.9.3 India Virology Specimen Collection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Becton,Dickinson and Company
7.1.1 Becton,Dickinson and Company Profile
7.1.2 Becton,Dickinson and Company Main Business
7.1.3 Becton,Dickinson and Company Virology Specimen Collection Products, Services and Solutions
7.1.4 Becton,Dickinson and Company Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.1.5 Becton,Dickinson and Company Recent Developments
7.2 Quidel Corporation
7.2.1 Quidel Corporation Profile
7.2.2 Quidel Corporation Main Business
7.2.3 Quidel Corporation Virology Specimen Collection Products, Services and Solutions
7.2.4 Quidel Corporation Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.2.5 Quidel Corporation Recent Developments
7.3 Trinity Biotech
7.3.1 Trinity Biotech Profile
7.3.2 Trinity Biotech Main Business
7.3.3 Trinity Biotech Virology Specimen Collection Products, Services and Solutions
7.3.4 Trinity Biotech Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.3.5 Titan Biotech Recent Developments
7.4 Titan Biotech
7.4.1 Titan Biotech Profile
7.4.2 Titan Biotech Main Business
7.4.3 Titan Biotech Virology Specimen Collection Products, Services and Solutions
7.4.4 Titan Biotech Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.4.5 Titan Biotech Recent Developments
7.5 Diasorin SA
7.5.1 Diasorin SA Profile
7.5.2 Diasorin SA Main Business
7.5.3 Diasorin SA Virology Specimen Collection Products, Services and Solutions
7.5.4 Diasorin SA Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.5.5 Diasorin SA Recent Developments
7.6 Vircell S.L.
7.6.1 Vircell S.L. Profile
7.6.2 Vircell S.L. Main Business
7.6.3 Vircell S.L. Virology Specimen Collection Products, Services and Solutions
7.6.4 Vircell S.L. Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.6.5 Vircell S.L. Recent Developments
7.7 Copan Italia S.P.A
7.7.1 Copan Italia S.P.A Profile
7.7.2 Copan Italia S.P.A Main Business
7.7.3 Copan Italia S.P.A Virology Specimen Collection Products, Services and Solutions
7.7.4 Copan Italia S.P.A Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.7.5 Copan Italia S.P.A Recent Developments
7.8 Puritan Medical Products Co.
7.8.1 Puritan Medical Products Co. Profile
7.8.2 Puritan Medical Products Co. Main Business
7.8.3 Puritan Medical Products Co. Virology Specimen Collection Products, Services and Solutions
7.8.4 Puritan Medical Products Co. Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.8.5 Puritan Medical Products Co. Recent Developments
7.9 Hardy Diagnostics
7.9.1 Hardy Diagnostics Profile
7.9.2 Hardy Diagnostics Main Business
7.9.3 Hardy Diagnostics Virology Specimen Collection Products, Services and Solutions
7.9.4 Hardy Diagnostics Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.9.5 Hardy Diagnostics Recent Developments
7.10 Cardinal Health
7.10.1 Cardinal Health Profile
7.10.2 Cardinal Health Main Business
7.10.3 Cardinal Health Virology Specimen Collection Products, Services and Solutions
7.10.4 Cardinal Health Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.10.5 Cardinal Health Recent Developments
7.11 Sarstedt
7.11.1 Sarstedt Profile
7.11.2 Sarstedt Main Business
7.11.3 Sarstedt Virology Specimen Collection Products, Services and Solutions
7.11.4 Sarstedt Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.11.5 Sarstedt Recent Developments
7.12 FL Medical
7.12.1 FL Medical Profile
7.12.2 FL Medical Main Business
7.12.3 FL Medical Virology Specimen Collection Products, Services and Solutions
7.12.4 FL Medical Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.12.5 FL Medical Recent Developments
7.13 Improve Medical
7.13.1 Improve Medical Profile
7.13.2 Improve Medical Main Business
7.13.3 Improve Medical Virology Specimen Collection Products, Services and Solutions
7.13.4 Improve Medical Virology Specimen Collection Revenue (US$ Million) & (2019-2024)
7.13.5 Improve Medical Recent Developments
8 Industry Chain Analysis
8.1 Virology Specimen Collection Industrial Chain
8.2 Virology Specimen Collection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Virology Specimen Collection Sales Model
8.5.2 Sales Channel
8.5.3 Virology Specimen Collection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Becton,Dickinson and Company
Quidel Corporation
Trinity Biotech
Titan Biotech
Diasorin SA
Vircell S.L.
Copan Italia S.P.A
Puritan Medical Products Co.
Hardy Diagnostics
Cardinal Health
Sarstedt
FL Medical
Improve Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.